Brian Druker

Professor

  • 62894 Citations
  • 108 h-Index
1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 26 Similar Profiles
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Tyrosine Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Phosphorylation Chemical Compounds
Mutation Medicine & Life Sciences
Myeloid Cells Medicine & Life Sciences
bcr-abl Fusion Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1987 2017

MUTAGENESIS OF POLYOMA MIDDLE-T ANTIGEN

Druker, B.

National Institutes of Health

4/13/87 → …

Project: Research projectPostdoctoral Individual National Research Service Award

Accelerating target identification and validation in leukemia: Integrating siRNA-

Druker, B.

National Institutes of Health

9/30/098/31/11

Project: Research projectNIH Challenge Grants and Partnerships Program

Small Interfering RNA
Leukemia
Neoplasms
RNA Interference
Gene Expression

Cancer and Kinases

Druker, B.

National Institutes of Health

9/1/058/31/06

Project: Research projectConference

Phosphotransferases
Pharmaceutical Preparations
Neoplasms
Clinical Trials
Enzymes

TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS

Druker, B.

National Institutes of Health

7/9/996/30/04

Project: Research projectMidcareer Investigator Award in Patient-Oriented Research

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Antineoplastic Agents
Protein-Tyrosine Kinases
Clinical Trials, Phase I
Hematopoietic Stem Cells

CBL FUNCTION IN CELLULAR SIGNALING AND TRANSFORMATION

Druker, B.

National Institutes of Health

1/1/9912/31/04

Project: Research projectResearch Project

Tyrosine
Phosphorylation
src Homology Domains
Protein-Tyrosine Kinases
Research Personnel

Research Output 1981 2019

Reply to n. Cerveira et al

Berman, E., Druker, B. & Burwick, R., Jan 1 2019, In : Journal of Clinical Oncology. 37, 1, 1 p.

Research output: Contribution to journalLetter

A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia

Zabriskie, M. S., Antelope, O., Verma, A. R., Draper, L. R., Eide, C. A., Pomicter, A. D., Tran, T. H., Druker, B., Tyner, J., Miles, R. R., Graham, J. M., Hwang, J. Y., Varley, K. E., Toydemir, R. M., Deininger, M. W., Raetz, E. A. & O’Hare, T., Jan 31 2018, In : Haematologica. 103, 2, p. e87-e91

Research output: Contribution to journalComment/debate

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Pediatrics

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia

Watanabe-Smith, K., Druker, B., Tyner, J. & Edwards, D. K., Jul 31 2018, In : Haematologica. 103, 8, p. e351-e355

Research output: Contribution to journalLetter

Decision Trees
Acute Myeloid Leukemia
4 Citations

Chronic myelogenous leukemia: Pregnancy in the era of stopping tyrosine kinase inhibitor therapy

Berman, E., Druker, B. & Burwick, R., Apr 20 2018, In : Journal of Clinical Oncology. 36, 12, p. 1250-1256 7 p.

Research output: Contribution to journalReview article

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Pregnancy
Therapeutics

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia

Kurtz, S. E., Eide, C. A., Kaempf, A., Mori, M. T., Tognon, C. E., Borate, U., Druker, B. & Tyner, J., Sep 1 2018, In : Leukemia. 32, 9, p. 2025-2028 4 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Phosphotransferases
Therapeutics